These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33222540)

  • 1. The management of phenylketonuria in adult patients in Italy: a survey of six specialist metabolic centers.
    Burlina A; Leuzzi V; Spada M; Carbone MT; Paci S; Tummolo A
    Curr Med Res Opin; 2021 Mar; 37(3):411-421. PubMed ID: 33222540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian national consensus statement on management and pharmacological treatment of phenylketonuria.
    Burlina A; Biasucci G; Carbone MT; Cazzorla C; Paci S; Pochiero F; Spada M; Tummolo A; Zuvadelli J; Leuzzi V
    Orphanet J Rare Dis; 2021 Nov; 16(1):476. PubMed ID: 34784942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.
    Giżewska M; MacDonald A; Bélanger-Quintana A; Burlina A; Cleary M; Coşkun T; Feillet F; Muntau AC; Trefz FK; van Spronsen FJ; Blau N
    Eur J Pediatr; 2016 Feb; 175(2):261-72. PubMed ID: 26350228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of phenylketonuria in Europe: survey results from 19 countries.
    Blau N; Bélanger-Quintana A; Demirkol M; Feillet F; Giovannini M; MacDonald A; Trefz FK; van Spronsen F;
    Mol Genet Metab; 2010 Feb; 99(2):109-15. PubMed ID: 19800826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complete European guidelines on phenylketonuria: diagnosis and treatment.
    van Wegberg AMJ; MacDonald A; Ahring K; Bélanger-Quintana A; Blau N; Bosch AM; Burlina A; Campistol J; Feillet F; Giżewska M; Huijbregts SC; Kearney S; Leuzzi V; Maillot F; Muntau AC; van Rijn M; Trefz F; Walter JH; van Spronsen FJ
    Orphanet J Rare Dis; 2017 Oct; 12(1):162. PubMed ID: 29025426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of adult patients with phenylketonuria: survey results from 24 countries.
    Trefz FK; van Spronsen FJ; MacDonald A; Feillet F; Muntau AC; Belanger-Quintana A; Burlina A; Demirkol M; Giovannini M; Gasteyger C
    Eur J Pediatr; 2015 Jan; 174(1):119-27. PubMed ID: 25480112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phenylketonuria (PKU) in Iceland].
    Oddason KE; Eiriksdóttir L; Franzson L; Dagbjartsson A
    Laeknabladid; 2011 Jun; 97(6):349-52. PubMed ID: 21659675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: Results from a survey with 228 patients and their caregivers.
    Martins AM; Pessoa ALS; Quesada AA; Ribeiro EM
    Mol Genet Metab Rep; 2020 Sep; 24():100624. PubMed ID: 32742934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study.
    Demirdas S; Maurice-Stam H; Boelen CC; Hofstede FC; Janssen MC; Langendonk JG; Mulder MF; Rubio-Gozalbo ME; van Spronsen FJ; de Vries M; Grootenhuis MA; Bosch AM
    Mol Genet Metab; 2013; 110 Suppl():S49-56. PubMed ID: 24100246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of children and adults with phenylketonuria in the NBS-PKU Connect registry.
    Kenneson A; Singh RH
    Mol Genet Metab; 2021 Nov; 134(3):243-249. PubMed ID: 34654619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria.
    Burton BK; Jones KB; Cederbaum S; Rohr F; Waisbren S; Irwin DE; Kim G; Lilienstein J; Alvarez I; Jurecki E; Levy H
    Mol Genet Metab; 2018 Nov; 125(3):228-234. PubMed ID: 30266197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Genetic Landscape and Epidemiology of Phenylketonuria.
    Hillert A; Anikster Y; Belanger-Quintana A; Burlina A; Burton BK; Carducci C; Chiesa AE; Christodoulou J; Đorđević M; Desviat LR; Eliyahu A; Evers RAF; Fajkusova L; Feillet F; Bonfim-Freitas PE; Giżewska M; Gundorova P; Karall D; Kneller K; Kutsev SI; Leuzzi V; Levy HL; Lichter-Konecki U; Muntau AC; Namour F; Oltarzewski M; Paras A; Perez B; Polak E; Polyakov AV; Porta F; Rohrbach M; Scholl-Bürgi S; Spécola N; Stojiljković M; Shen N; Santana-da Silva LC; Skouma A; van Spronsen F; Stoppioni V; Thöny B; Trefz FK; Vockley J; Yu Y; Zschocke J; Hoffmann GF; Garbade SF; Blau N
    Am J Hum Genet; 2020 Aug; 107(2):234-250. PubMed ID: 32668217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe.
    Lowe TB; DeLuca J; Arnold GL
    Orphanet J Rare Dis; 2020 Sep; 15(1):266. PubMed ID: 32977849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
    Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
    Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000.
    National Institutes of Health Consensus Development Panel
    Pediatrics; 2001 Oct; 108(4):972-82. PubMed ID: 11581453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians' current practices.
    Yuskiv N; Potter BK; Stockler S; Ueda K; Giezen A; Cheng B; Langley E; Ratko S; Austin V; Chapman M; Chakraborty P; Collet JP; Pender A;
    Orphanet J Rare Dis; 2019 Jan; 14(1):7. PubMed ID: 30621767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKU dietary handbook to accompany PKU guidelines.
    MacDonald A; van Wegberg AMJ; Ahring K; Beblo S; Bélanger-Quintana A; Burlina A; Campistol J; Coşkun T; Feillet F; Giżewska M; Huijbregts SC; Leuzzi V; Maillot F; Muntau AC; Rocha JC; Romani C; Trefz F; van Spronsen FJ
    Orphanet J Rare Dis; 2020 Jun; 15(1):171. PubMed ID: 32605583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to clinic recommendations among patients with phenylketonuria in the United States.
    Jurecki ER; Cederbaum S; Kopesky J; Perry K; Rohr F; Sanchez-Valle A; Viau KS; Sheinin MY; Cohen-Pfeffer JL
    Mol Genet Metab; 2017 Mar; 120(3):190-197. PubMed ID: 28162992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to tetrahydrobiopterin therapy in patients with phenylketonuria.
    Rohr F; Wessel A; Brown M; Charette K; Levy HL
    Mol Genet Metab; 2015 Jan; 114(1):25-8. PubMed ID: 25467057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.